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Increased sporulation underpins 
adaptation of Clostridium difficile 
strain 630 to a biologically–
relevant faecal environment, with 
implications for pathogenicity
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James William Allwood 2, Susan Verrall2, Christopher Ian Richard Gill 1, 
James Stephen Gerard Dooley  1 & Geoff McMullan 3
Clostridium difficile virulence is driven primarily by the processes of toxinogenesis and sporulation, 
however many in vitro experimental systems for studying C. difficile physiology have arguably limited 
relevance to the human colonic environment. We therefore created a more physiologically–relevant 
model of the colonic milieu to study gut pathogen biology, incorporating human faecal water (FW) 
into growth media and assessing the physiological effects of this on C. difficile strain 630. We identified 
a novel set of C. difficile–derived metabolites in culture supernatants, including hexanoyl– and 
pentanoyl–amino acid derivatives by LC-MSn. Growth of C. difficile strain 630 in FW media resulted 
in increased cell length without altering growth rate and RNA sequencing identified 889 transcripts 
as differentially expressed (p < 0.001). Significantly, up to 300–fold increases in the expression of 
sporulation–associated genes were observed in FW media–grown cells, along with reductions in 
motility and toxin genes’ expression. Moreover, the expression of classical stress–response genes did 
not change, showing that C. difficile is well–adapted to this faecal milieu. Using our novel approach we 
have shown that interaction with FW causes fundamental changes in C. difficile biology that will lead to 
increased disease transmissibility.
The Gram–positive spore–forming anaerobe Clostridium difficile is recognised as one of the major causes of 
health-care associated infections1,2 and exerts a negative and well–publicised impact on hospital morbidity and 
mortality rates1. C. difficile infection (CDI) can develop when broad spectrum antibiotics are deployed to treat 
underlying infections: they disrupt the body’s natural colonic microbiota thus allowing development of CDI if 
spores or cells of this multidrug–resistant pathogen are also present3. Colonisation of the host gastrointestinal 
tract depends on the germination of C. difficile spores, with subsequent growth of vegetative cells and the release 
of two large clostridial glycosylating toxins, toxin A and toxin B4. These toxins are responsible for the inflamma-
tion and epithelial tissue damage that results in rapid loss of fluid and consequent diarrhoea5. Clinical manifes-
tations and severity of CDI vary from mild self-limiting diarrhoea to life-threatening pseudomembranous colitis 
and, in severe cases, death6.
While it is well established that gut microbiome disruption by antibiotics can lead to the development of C. 
difficile infection (CDI)6, the mechanisms underlying C. difficile expansion after microbiota disturbance are only 
just emerging. Both dietary and microbiota compositional changes have been demonstrated to lead to alterations 
in the colonic environment that favour or suppress certain enteric pathogens such as C. difficile7–11 and indeed 
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C. difficile virulence has been linked to the ability to both effectively utilise nutrients in the dysbiotic gut envi-
ronment12 and to sporulate13. During CDI, there is rapid expansion of the C. difficile vegetative cell population, 
with subsequent production of the two proven virulence factors, the toxins (A&B), and spores which serve as the 
transmissible elements14,15.
While a variety of model systems that are indispensable in the study of C. difficile pathogenesis have been 
described16, studies with humans are, by contrast, limited to prospective or retrospective sampling and elucida-
tion of C. difficile strain variants. While it could be argued that many of the experimental systems that exist to 
study C. difficile pathogenesis have rather limited relevance to the human gut, recent work with in vitro contin-
uous flow bioreactors has elegantly demonstrated the increased competitive fitness of ribotype 027 C. difficile 
strains in a mixed microbiota model17 and shown that microbial communities representative of key features of the 
gut can be cultivated and manipulated successfully18. Such in vitro models have also been used to investigate and 
model antibiotic exposure19, intestinal biofilm development20 and genomic stability of C. difficile during simu-
lated infection experiments21. In other systems that seek to investigate changes within the human gut, faecal water 
(FW), the aqueous phase of human faeces22, is an attractive means of linking changes in colonic contents with gut 
health outcomes23–27. FW has been used as a biologically–relevant challenge agent in a range of gut studies28–30 
as it contains a variety of unbound, soluble components including bile acids, fatty acids, amino acid residues and 
derivatives, (poly)phenols, and short-chain fatty acids31–33. These metabolites are likely to modulate the function 
and composition of the microbiome. To allow physiologically–relevant modelling of C. difficile under controlled 
culture conditions, we have incorporated FW into growth media in order to better mimic the human gut envi-
ronment. Using our novel approach we now demonstrate for the first time that expression of genes essential for 
pathogenesis are significantly differentially expressed in the human faecal water milieu.
Results and Discussion
C. difficile cell length increases, yet overall population growth is unaffected in FW media. To 
create a physiologically more relevant model of the colonic milieu to study gut pathogen biology, a pooled faecal 
water (FW) sample was produced as previously described32 from two male donors (age 40+/−2 years). We char-
acterised the FW using LC–MSn and demonstrated that it contained components identified in previous investi-
gations32,34–36. Some 30 FW components, many of which are known constituents of faeces (e.g. stercobilin and 
urobilinogen) were identified (Table 1), while others gave MS data and putative IDs consistent with previous 
analyses including a number of bile acid derivatives37 as well as some unidentified components.
To test the hypothesis that the presence of faecal water would change C. difficile physiology in a way more 
reflective of the in vivo environment, we compared growth in faecal water/BHIS growth media (“FW media”) with 
the BHIS control. FW media was not detrimental to growth of C. difficile strain 630 over 6 h (Fig. 1A), although 
we noted that bacterial cell length increased by almost 70% at 6 h in FW media (4.3 µm versus 3.3 µm, p = 0.015) 
(Fig. 1B). (Supplementary Data File 1, Tables S1 and S2)
C. difficile generates novel, amino-acid derived metabolites during growth in FW media. Having 
demonstrated that C. difficile population growth was not affected by the presence of FW components, we deter-
mined whether any of the FW components were utilised by C. difficile during growth, or if any bacterially–derived 
metabolites could be identified in culture supernatants. FW–derived components (n = 30) were not subject to 
further metabolism or degradation by C. difficile and were largely unchanged between the start and end of the 
6 h incubation (Fig. 2A). The main trend was towards a slight increase in abundance during incubation (Fig. 2B, 
Table 2), possibly caused by release of FW components bound to BHI media constituents during growth of C. 
difficile.
We focused on metabolites whose abundance consistently increased during incubation, using the XCMS pro-
cess with data checking to eliminate low abundance peaks, adducts and multiply charged ions (see Supplementary 
Data File 1, Figs S1–S6). Overall, there was an increase in certain components, most notably a set of amino 
acids esterified to hexanoic and pentanoic acids including glycine, lysine, alanine, tyrosine, methionine, valine, 
phenylalanine, tryptophan and leucine and/or isoleucine. No threonine, arginine, histidine, asparagine, aspar-
tate, cysteine, glutamine, proline or serine hexanoyl derivatives were found. These putative hexanoyl amino-acid 
derivatives yielded characteristic MS2 fragments which suggested fragmentation at the amide bond to produce 
the M[−H] ion of the amino acid and a neutral loss of 98 atomic mass units (amu), which could be due to the 
aldehyde, hexenal (C6H10O). In a similar manner, fragmentation of pentanoyl derivatives produced the M[−H] 
ion of the amino acid and a neutral loss of 84 amu due to the aldehyde, pentenal, (C5H8O; 14 amu less than hex-
enal). Other common fragmentations can be assigned (i.e. neutral loss of 42 (C3H6 = propene), neutral loss of 
56 (C4H8 = butene), neutral loss of 70 (C5H10 = pentene) and are consistent with such structures. Other neutral 
losses such as 44 and 46 amu, respectively, can be ascribed to CO2 and formic acid from the amino acid com-
ponents. These putative hexanoyl and pentanoyl amino acid derivatives have not previously been identified in 
cultures of C. difficile but this microorganism is known to produce isocaproic acid (also known as isohexanoic 
acid) during growth and the accumulation of this C6 fatty acid has previously been used as a diagnostic for C. 
difficile in stool samples38,39. Investigations into biofuel production by Clostridia have shown that hexanoyl–coA 
is a key metabolite for the production of hexanol40 and the formation of these putative hexanoyl and pentanoyl 
amino-acid derivatives may be a consequence of growth of C. difficile in the amino acid–rich BHI media. Earlier 
work showing isocaproic acid accumulation38,39 used less sensitive GC–MS techniques that required sample deri-
vatisation and thus would not have detected the amino acid derivatives we identified. Of all the metabolites 
whose abundance increased during growth of C. difficile (Table 2), only hexanoyl lysine (peak 5, −m/z 243) was 
higher in the BHI media than in FW media (Supplementary Data File 1, Fig. S5). In fact, growth of C. difficile in 
the presence of FW did not reduce the levels of any of the other putatively–identified novel components (i.e. six 
components were substantially increased and four components marginally increased).
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Considerable modulation of the C. difficile transcriptome results from growth in FW media. 
Some 889 C. difficile strain 630 transcripts were differentially expressed (DE) (padj < 0.001, fold–change 
(FC) > 1.45) as a result of exposure to faecal water with 497 (56%) exhibiting increased expression and 392 
(41%) being decreased (Supplementary Table S3). The largest numbers of DE genes were in categories “Similar 
to unknown proteins” (16%), “Transport binding proteins and lipoproteins” (14.4%), “Metabolism of amino 
acids and related molecules” (7.9%), “Transposon and IS function” (6.2%), “Sporulation” (6.8%), “Specific met-
abolic pathways” (5.7%), and regulation of RNA synthesis (4.8%) (Fig. 3). Orthogonal validation of expressional 
changes using qRT-PCR showed good correlation (R2 = 0.95) between RNAseq and qRT-PCR data (Fig. 4) 
(Supplementary Data File 1, Table S4) when applied to a number of motility and sporulation genes.
We noted that within the 889 DE genes, a slightly larger proportion exhibited increased expression in FW 
media with the exception of those in the categories of signal transduction, motility, genes associated with spe-
cific pathways, metabolism of co–factors, and detoxification (Fig. 5). Considerable expressional changes in the 
transcriptional programme of C. difficile strain 630 were apparent in regard to genes associated with sporulation, 
protein synthesis and protein modification. Nine sporulation–associated genes exhibited > 100–fold increases in 
expression however the largest absolute increase in expression (445–fold) was in CD1065, which encodes a 146 
amino acid ‘conserved hypothetical protein’. A number of investigations into C.difficile sporulation have indicated 
that CD1065, and indeed a number of genes encoded by CD1063A-CD1067, are strongly regulated by either σE 
or σK, with published data indicating that CD1065 is strongly induced by σE in the mother cell during sporu-
lation41–43. The largest decreases in expression (>100–fold) were in a three–gene ATP binding cassette (ABC) 
transporter operon encoded by CD0873–0875. The largest fold–changes in gene expression were found in the 
categories of (i) transport, binding proteins and lipoproteins (up to 270–fold), (ii) sporulation (up to 300–fold), 
and (iii) genes encoding hypothetical proteins (up to 445–fold). Genes involved in specific metabolic pathways, 
Peaka RTb m/z [M-H]− MS2c
Formulad m/z 
[M-H]− Putative Identity Reference/Database
1 5.32 181.0357 138 (43) 122 (59) C6H5N4O3 Xanthine (1-methyl uric acid) Jiménez-Girón et al.36
2 5.83 131.0345 113 (18) 87 (44) C5H704 Hydroxy-oxopentanoic acid ChEBI:111517
3 9.23 145.0500 127 (18) 101 (44) 83 (62) C6H9O4 Adipic acid (hexanedioic acid) ChEBI:30832
4 10.15 357.0735 339 [18] 313 [44] 277 [80] 260 [97] ND UK (277-sulphate) NA
5 10.71 195.0514 180 [15] C9H9ON UK NA
6 11.87 + 12.13 261.0059 181 [80] C9H9O7S Homovanillic acid sulphate ChEBI:88405
7 12.93 181.0497 163 [18] 137 [44] 113 [68] C9H9O7 Homovanillic acid ChEBI:545959
8 14.83 305.0681 225 [80] 97 [128] C12H17O7S UK (225-sulphate) NA
9 17.85 165.0549 147 [18] 121 [44] 97 [68] C9H9O3 Hydroxyphenylpropionic acid ChEBI:32980
10 22.27 187.0966 169 [18] 125 [62] 97 [90] C9H15O4 Azelaic acid (nonanedioic acid) ChEBI:48131
11 22.69 329.1007 311 [18] 285 [44] 249 [80] 205 [128] 123 [206] ND UK (249-sulphate) NA
12 23.84 199.0964 155 [44] 181 [18] C10H15O4 Decenedioic acid ChEBI:89730
13 24.11 359.1109 315 [44] 341 [18] C19H19O7 Unknown NA
14 24.35 389.1215 345 [44] 313 [68] 271 [118] C20H21O8 Dehydro-deoxycholic acid NA
15 24.69 413.1609 395 [18] 383 [30] 369 [44] 353 [60] 333 [80] C20H29O7S UK (333-sulphate) NA
16 25.16 413.1609 395 [18] 383 [30] 369 [44] 353 [60] 333 [80] C20H29O7S UK (333-sulphate) NA
17 25.40 + 26.16 201.1121 139 [62] 157 [44] C10H17O4 Decanedioic acid ChEBI:41865
18 25.69 453.2824 435 [18] 407 [46] C25H41O7 Cholic acid 1 (+formate) LMST04010001
19 25.87 319.1642 301 [18] 291 [28] 273 [46] C17H23N2O4 UK
20 26.75 591.3143 547 [44] C33H43N4O6 Urobilinogen ChEBI:29026
21 26.92 593.3297 549 [44] C33H45N4O6 Stercobilin ChEBI:26756
22 27.84 453.2824 435 [18] 409 [44] 407 [46] C25H41O7 Cholic acid 2 (+formate) LMST04010001
23 29.16 485.2178 331 [154] 259 [226] C27H33O8 Bile acid derivative NA
24 29.46 453.2826 435 [18] 407 [46] 391 [62] C25H41O7 Cholic acid 3 (+formate) LMST04010001
25 30.14 + 30.49 471.2390 391 [80] 453 [18] 427 [44] C24H39O7S Sulfodeoxycholic acid ChEBI:88888
26 31.10 453.2826 435 [18] 407 [46] 373 [80] C25H41O7 Cholic acid 4 (+formate) LMST04010001
27 31.27 451.2667 433 [18] 407 [44] C25H39O7 dehydrocholic acid (+formate) PB 6674
28 32.11 471.2390 453 [18] 421 [50] 378 [93] 373 [98] C24H39O7S Sulfodeoxycholic acid ChEBI:88888
29 32.41 531.2198 513 [18], 489 [42] 471 [60] 427 [104] C32H35O5S Cyprinol sulphate-like bile acid derivative HMDB 0006888
30 33.24 453.2822 435 [18] 409 [44] 407 [46] C25H41O7 Cholic acid 5 (+formate) LMST04010001
Table 1. Components identified in faecal water. Most of these peaks were present in media at the end of the 
incubation. Most were unchanged during growth of Clostridium difficile strain 630 but some were marginally 
increased. Databases: PB = PubChem (https://pubchem.ncbi.nlm.nih.gov/); ChEBI (http://www.ebi.ac.uk/
chebi/); LM - LIPID MAPS (http://www.lipidmaps.org/data/structure/); HMDB (http://www.hmdb.ca/). apeak 
designation; bretention time; cMS2 fragments in bold are the most intense; figures in brackets are neutral loss. All 
MS2 fragments apart from bold or underlined are minor fragments; dpredicted formulae based on m/z [M-H] 
values, UK = unknown.
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RNA metabolism, protein modification, adaptation to atypical conditions and those categorised as miscellaneous 
exhibited fold changes of no more than 20–fold. The least extensively–changed genes were those involved with 
metabolism of phosphorus, sulphur, lipids, and coenzymes (Fig. 6), indicating that these central metabolic path-
ways were relatively unperturbed in the presence of FW. We have previously demonstrated apparent robustness of 
C. difficile central metabolic pathways under mild heat stress44–46, however the extreme perturbations in sporula-
tion, transport and conserved hypothetical protein–encoding genes led us to consider these biological processes, 
and their implications for the lifestyle of this important pathogen, in detail.
C. difficile sporulation gene expression increases during growth in FW media. In the model 
Gram positive organism Bacillus subtilis, and also in C. difficile, sporulation is initiated by a two–component 
system with Spo0A and associated kinases47,48, leading to the sequential, compartment–specific activation of 
the strictly conserved sporulation–specific sigma factors, σH (early), σF, σE, σG, and σK (late)47,49. Thereafter, 
however, differences have been shown in the order, activation, and function of the sigma factors in C. difficile50. 
Genome–wide mutational analyses of sigma factor function in C. difficile have revealed that while their transcrip-
tional and functional sequence (sigE & sigF – early, sigG & sigK – late) is broadly conserved with the B. subtilis 
model, there are differences in the C. difficile developmental programme51. Spores were not visible in cultures of 
sigma factor mutants, indicating their critical role in the various stages of sporulation and in the production of 
mature, heat-resistant spores42. Intriguingly, and in contrast to B. subtilis, the activity of σE was partially inde-
pendent of σF; σG or σK did not require σE or σG, respectively and sigG transcription was not dependent on 
σF41,42. Taken together, the published data suggests minimal intercompartmental communication and a weaker 
connection between forespore and mother cell50, in addition to a looser association between gene expression and 
morphology in C. difficile41,51. While sporulation in C. difficile is more akin to B. subtilis than to other Clostridia, 
it at the same time represents a more ancestral, less tightly–controlled sporulation programme that facilitates 
a degree of population heterogeneity during infection52. The recent work of Browne et al.53 showed extensive 
sporulation ability within the human gut microbiota, with many taxa present in the spore form. Animal models 
of C. difficile infection have revealed that in mouse, C. difficile spores germinate by 6 h post–infection, leading to 
pathogenic lesions and heat–resistant spores – comprising up to 20% of the total cfu – being detectable 24–36 h 
post–challenge. Thus, while sporulation under infection conditions takes some time) with C. difficile strain 63015, 
Figure 1. Growth of Clostridium difficile strain 630 in faecal water media. (A) Growth (D650mn) of Clostridium 
difficile strain 630 in faecal water media and in BHIS. Data presented are means of three independent biological 
replicates and error bars represent the standard deviation of the mean. (B) Cell lengths of Clostridium difficile 
strain 630 grown in faecal water media and in BHIS. Samples from growth curves shown in (A) were Gram’s 
stained by standard methods and 100 cells were measured per sample. The data presented are the means of 
3 biologically independent experiments and error bars represent standard deviation of the mean. P values 
represent statistical comparison (Anova, Post hoc: Dunnett t (2-sided)) between other time points and T = 0; 
T4, p = 0.010, T5, p = 0.006, T6 p = 0.015.
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the process happens as early as 6 h post–infection with the ribotype 027 strain, C. difficile R2029154. Temporal 
examination of C. difficile 630 gene expression during infection in mouse55 and pig ligated loop models56 has 
shown that many genes associated with host adaptation, all stages of sporulation and a diversity of genes encoding 
“hypothetical proteins” were expressed at increased levels in vivo, indicating their importance in the infection 
process and the requirement for extensive remodelling of the transcriptome during infection. We thus hypoth-
esised that FW would induce sporulation in C. difficile and sporulation genes were indeed some of the most 
Figure 2. Metabolite peaks that changed during growth of Clostridium difficile strain 630 in faecal water 
media. (A) Metabolite peaks derived from faecal water (Identities in Supplementary Data File 1, Table S1). (B) 
Metabolite Peaks that changed during growth of C. difficile strain 630. Peaks A–R were noted to alter between 
the MS traces of the 0 h and 6 h time points while peaks 1–17 were noted as being increased during growth using 
the XCMS data processing method (Identities in Supplementary Data File 1, Table 2).
www.nature.com/scientificreports/
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differentially expressed in FW medium, with increases up to 300–fold. Of 60 DE genes in our dataset that had a 
predicted or known role in sporulation, only two exhibited decreased expression (CD2273, a ‘putative sporulation 
integral membrane protein’–possibly under σE control, and CD3669, a ‘putative exported protein’–part of the 
mature spore proteome). Of the remaining 58 genes, the expression of 22 of these was increased > 50–fold, indi-
cating that FW is a potent inducer of sporulation genes in C. difficile strain 630. C. difficile sporulation has been 
extensively mapped, allowing definition of genes under control of Spo0A (CD1214, increased by 2.5–fold)–the 
Peaka RTb
Comparison of change 
in metabolite over time 
(0–6 hr) between FW & BHIc m/z [M-H]− MS2d
Formulae 
[M-H]− Putative Identity Database
1 5.18 ↑ FW > ↑ BHI 144.0658 126 (18), 116 (28), 100 (44), 98 (46),74 (70) C6H10NO3 N-butyryl glycine PC 88412
2 8.03 ↑ FW > ↑ BHI 149.0270 119 (30), 101 (48), 89 (60), 83 (66) C5H9SO3 hydroxyl (methylthio) butanoic acid PC 11427
3 8.88 9.97 ↑ FW > ↑ BHI ↑FW = ↑ BHI 158.0813 158.0813
114 (44), 112 (46), 102 (56), 88 (70), 
74 (84) 131 (27), 116 (42), 114 (44), 
102 (56), 88 (70) 86 (72), 74 (84)
C7H12NO3 
C7H12NO3
pentanoyl glycine isomers NA
A 9.92 ↑FW = ↑ BHI 227.1024 183 (44) C10H15N2O4 pyroglutamyl valine** PC 152416
B 10.60 ↓ FW = ↓ BHI 259.0741 215 (44), 211 (48), 167 (92) C18H11O2 pyreneacetic acid PC 186770
4 10.66 ↑FW = ↑ BHI 181.0494 163 (18), 135 (46),119 (62) C9H9O4 homovanillic acid CS 1675
5 11.28 ↑FW < ↑ BHI 243.1696 225 (18), 199 (44), 182(61) 163 (80), 145 (98), 130 (113) 128 (115) C12H23N2O3 hexanoyl lysine CS 7992036
C 11.35 ↓ FW = ↓ BHI 269.0761 225 (44), 122 (147) C11H13N2O6 UK
6 11.51 ↑FW = ↑ BHI 222.0756 180 (42), 178 (44), 163 (59) C11H12NO4 N-acetyl tyrosine PC 68310
D 13.45 ↑ FW > ↑ BHI 131.0707 85 (46) C6H11O3 hydroxycaproic acid PC 99824
E 13.79 ↑ FW > ↑ BHI 131.0706 85 (46) C6H11O3 hydroxycaproic acid isomer PC 99824
7 14.85 ↑ FW > ↑ BHI 172.0968 130 (42), 128 (44), 88 (84), 74 (98) C8H14NO3 pentanoyl alanine CS 15621024
F 15.20 ↓ FW = ↓ BHI 241.1182 197 (44) C11H17N2O4 UK
8 16.18 ↑ FW > ↑ BHI 172.0966 154 (18), 130 (42), 128 (44), 88 (84), 74 (98) C8H14NO3 hexanoyl glycine (N-caproylglycine) CS 89859
G 16.66 ↑ FW > ↑ BHI 165.0546 147 (18), 119 (46) C9H9O3 3-(4-hydroxyphenyl) propionic acid PC 10394
9 16.75 ↑ FW > ↑ BHI 250.1065 206 (44), 180 (70), 163 (87) C13H17NO4 ethyl-N-acetyl tyrosine CS 12729
H 16.82 ↓ FW = ↓ BHI 273.0862 229 (44) C14H13N2O4
hexahydrophenazine-1,6-dicarboxylic 
acid
ChEBI 
132261
10 19.30 ↑ FW > ↑ BHI 186.1126 142 (44),130 (56), 88 (98), 86 (100) C9H16NO3 hexanoyl alanine NA
11 19.62 ↑ FW > ↑ BHI 264.1221 220 (44), 180 (84),163 (101) 158 (106),107 (157) C14H18NO4 pentanoyl tyrosine CS 5142226
12 20.12 ↑ FW > ↑ BHI 145.0861 127 (18), 99 (46), 97 (48) 83 (62) C7H13O3 hydroxy heptanoic acid PC 275049
J 20.65 ↓ FW = ↓ BHI 598.2504 390 (208), 372 (226) C29H36O9N5 UK
13 22.11 ↑ FW > ↑ BHI 200.1277 182 (18), 172 (28), 156 (44), 130 (70), 114 (86), 86 (114) C10H18NO3
capryloyl glycine (2-octanamidoacetic 
acid) CS 76040
K 23.15 ↑FW = ↑ BHI 385.1411 259 (126) C15H23N5SO5 UK NA
L 24.40 ↑FW = ↑ BHI 278.1374 234 (44), 260 (18), 180 (98) 163 (115) C15H20NO4 hexanoyl tyrosine CS 32674367
14 25.63 ↑ FW > ↑ BHI 273.1221 225 (18), 243 (30), 229 (44) None UK NA
15 26.67 ↑FW = ↑ BHI 246.1151 228 (18), 202 (44), 198 (48), 154 (92), 148 (98) C11H20NO3S hexanoyl methionine CS 80768
M 26.69 ↑FW = ↑ BHI 214.1434 196 (18), 170 (44),116 (98) C11H20NO3 hexanoyl valine CS 24223294
N 26.91 ↓ FW = ↓ BHI 740.4290 683 (57), 587 (152), 439 (301), 414 (326) C46H60O8 UK NA
16 27.47 ↑FW = ↑ BHI 248.1273 204 (44),164 (84),147 (101) 112 (136) C14H18NO3 pentanoyl phenylalanine CS 14753835
17 27.71 ↑FW = ↑ BHI 287.1377 243 (44),203 (84),158 (129) C16H19N2O3 pentanoyl tryptophan CS 16818921
O
P
29.43
29.76 ↑FW = ↑ BHI 228.1588 210 (18),184 (44), 130 (98) C12H22NO3 hexanoyl leucine/isoleucine CS 20041531
Q 30.40 ↑FW = ↑ BHI 301.1533 283 (18),257 (44) 203 (98) 172 (129) C17H21N2O3 hexanoyl tryptophan CS 53673714
R 30.62 ↑FW = ↑ BHI 262.1430 218 (44), 164 (98) 147 (115) C15H20NO3 hexanoyl phenylalanine CS 3440214
Table 2. Identified metabolites that changed during growth of Clostridium difficile strain 630 in FW media. 
Databases - PB = PubChem (https://pubchem.ncbi.nlm.nih.gov/); CS = Chem Spider (http://www.chemspider.
com/)., ChEBI (http://www.ebi.ac.uk/chebi/) Peaks A – R are featured in Fig. 3. **Identified in faecal water95 
apeak designation; bretention time; carrows denote whether the compound increases or decreases during 
the growth period; <, > and + denote if the increase or decrease was more apparent in the + FW or BHI 
alone incubations; dMS2 fragments in bold are the more intense, figures in brackets are neutral loss. All MS2 
fragments apart from bold or underlined are minor fragments; epredicted formulae based on m/z [M-H] values, 
UK = unknown.
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master regulator of sporulation–and the identification of potential links between sporulation and other pheno-
types41,42,52,57. Phosphorylation of the Spo0A protein initiates a sigma factor cascade that, acting in both mother 
cell and forespore, influences expression of the sporulation–specific sigma factors σF (CD0772, 9–fold up), σE 
(CD2643, 23–fold up), σG (CD2642, 40–fold up) and σK that control expression of early (Bacillus stage II and 
III) and late (Bacillus stage V and VI) sporulation genes50. During sporulation, a septum results in asymmetric 
division of the bacterial cell and creates two unequally–sized compartments. The smaller–the forespore–develops 
into the spore, while the larger compartment prepares the forespore for dormancy42,51. Taken in the context of 
previous identification/analysis of sporulation–associated genes48,53 our data indicates that, at the point of har-
vest, FW–grown C. difficile 630 cells are physiologically at what in B. subtilis would be categorised as stage III of 
sporulation, i.e. the point at which engulfment of the forespore has occurred, but prior to cortex formation. Thus, 
genes including the spoIIIAA–spoIIAH operon (all >50–fold increased), in addition to spoIIIJ (oxaA1, 1.6–fold 
increased), spoIIID (56–fold increased) and sigG (40–fold increased) exhibited considerably increased expression 
in FW–grown cells. Of the sporulation–associated sigma factors, σE exhibited the second–largest expressional 
increase (23–fold) in FW. The σE protein acts on a number of genes in the Clostridial sporulation cascade41,42 and 
we noted increased expression of σE–controlled genes including spoIIID, spoIVA (57–fold up), cspBA (22–fold 
up) and cspC (2.2–fold up). Furthermore, we observed increased expression of genes encoding certain spore coat 
proteins, including cotE (CD1433, 29–fold up). The peroxiredoxin and chitinase activities of CotE contribute to 
pathogenesis by facilitating degradation of gut mucus during infection58,59.
It has been demonstrated that decreased oppABC (CD0853–855, encoding an oligopeptide transporter) 
expression leads to earlier expression of sporulation–associated genes13 and the observation that oppABC expres-
sion was 50% lower in FW appears consistent with our other observations of FW–induced changes to the C. diffi-
cile transcriptome. Taken together, therefore, our gene expression data indicates that C. difficile cells are induced 
by FW components towards sporulation more rapidly than cells grown in BHIS media. The spores are the trans-
missible, resilient, and infectious form of the organism14 and thus our observation has clear implications for 
pathogenesis and transmission of the disease, in addition to being entirely consistent with observations by other 
researchers of extensive sporulation within the gut microbiota in vivo15,53–56.
A variety of C. difficile transport systems are differentially expressed in FW media. In previ-
ous work we showed that phosphotransferase (PTS) sugar transport systems were largely unperturbed by heat 
stress45. By contrast, our current investigation revealed considerable changes in transporter gene expression. The 
PTS is the major bacterial carbohydrate assimilation system for hexoses, hexitols and disaccharides and con-
sists of two general components–enzyme I (EI), and the histidine phosphocarrier protein (HPr)–in addition 
to sugar specific permeases (enzymes II) in the cell membrane. In FW media, expression of the gene encod-
ing the EI component (CD2755) common to, and essential for, all phosphotransferase systems in the cell, was 
increased by 1.58–fold. In contrast, expression of the HPr kinase/phosphorylase (CD3409) that phosphorylates 
Figure 3. Functional categorisation of differentially–expressed transcripts in the Clostridium difficile strain 630 
faecal water transcriptome.
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the cytoplasmic phosphocarrier protein Hpr at Ser42, and which also leads to activation of the LacI family carbon 
catabolite repressor, ccpA60, was 1.8–fold lower. Consistent with these observations, the gene encoding the IIABC 
component of the PTS system for uptake of beta-glucosides (bglF, CD0388) was increased, as was the down-
stream gene bglA (CD0389) encoding 6-phospho-beta-glucosidase, reflective of the likely increased availability 
of such glucoside substrates61 in the FW media. In addition, expression of the sorbitol specific IIB component, 
srlEa, (CD0765) was increased as was expression of CD2269 encoding the fructose specific IIABC component, 
fruABC, as were genes encoding the IIA and IIB components of the glucose PTS transport system (CD2512, 
CD2510, respectively). Expression of the IIC and IID components of the mannose/fructose/sorbose transport 
system (CD3277, CD3276) were increased by 4– and 6.6–fold, respectively. Conversely, expression of PTS system 
components associated with uptake of xylosides (xyl and xyn operons, CD3064–CD3070) was lower in FW, while 
expression of the associated transcriptional regulator (xylose repressor, xylR, CD3066), which functions to reduce 
expression of genes for uptake and metabolism of xylose, was increased. These diverse perturbations in expression 
of carbohydrate transport–associated genes most likely underpin an adaptive response of C. difficile to additional 
carbon sources and other diet derived metabolites present in the FW. However, the PTS is also a signalling device 
which has been linked to chemotaxis and regulatory functions associated with C, N and P metabolism and to 
the virulence of C. difficile62,63. The complex interplay between a variety of cellular systems (sugar transport, car-
bon catabolite repression, quorum sensing and amino acid metabolism), controls toxin production. It is known, 
for example, that butyrate stimulates toxin production60 but, in FW–grown cells we noted lower expression of 
12 genes associated with carbohydrate fermentation to butyrate. The likely reduction in metabolic flux towards 
butyrate is consistent with the 4–fold lower expression of tcdA (CD0663) observed in FW (Fig. 4). Other genes 
encoded by the pathogenicity locus are not discussed here as our padj cutoff value precluded their inclusion in the 
list of statistically significant DE genes.
Figure 4. Comparison of qRT-PCR and RNAseq data for selected Clostridium difficile strain 630 genes. For 
each individual gene, expressional changes determined by RNAseq (up-hatched columns) and by qRT-PCR 
(down-hatched columns) are shown relative to the BHIS control, and show good correlation between the two 
datasets (R2 = 0.97). rpsJ, gyrA and adk were used as reference genes.
Figure 5. Differentially–expressed genes in the Clostridium difficile strain 630 faecal water transcriptome 
by functional category. Orange – increased expression; blue – decreased expression, p < 0.001. Analysis was 
conducted only on functional categories within which > 5 genes were differentially expressed.
www.nature.com/scientificreports/
9SCIENtIFIC REPORTS |         (2018) 8:16691  | DOI:10.1038/s41598-018-35050-x
A number of ABC transporter–encoding genes were DE in FW, including some associated with transport of 
sugar phosphates, vitamins, oligopeptides, amino acids and also transporters associated with multidrug efflux 
mechanisms64. The most downregulated gene (270–fold lower in FW) in our dataset was an ABC transporter 
‘substrate-binding lipoprotein’ (CD0873), recently identified as an adhesin that enables C. difficile to bind Caco–2 
cells65. Our data suggests that, in FW at the point of cell harvest and possibly at later stages in the infection cycle 
in a host, C. difficile exhibits reduced binding to epithelial cells, consistent with increased sporulation and lowered 
motility. This physiological state could thus facilitate evacuation of the bacterial population from the host. Ten 
different lantibiotic/multidrug ABC transporters were also DE. Four exhibited increased expression–CD0161 
(4.73–fold); CD1349/50 (5.3, 2.9–fold); CD2210/11 (3.7, 2.5–fold); CD2406/7/8 (all 2.58–fold up). The precise 
function of such transporters has not yet been defined, and consequently genomic annotations are a “general 
function prediction” only. Nonetheless, within the intestine, C. difficile and other gut pathogens must contend 
with innate host defences including cationic antimicrobial peptides (CAMPs, e.g., nisin) produced by both 
host and indigenous microbiota64,66. McBride and Sonenshine67 have shown that proteins encoded by CD1349/
CD1350 are involved in resistance to CAMPs, proposing the designation cprABC-cprK for CD1349 to CD1352. In 
FW–grown C. difficile cells, expression of CD1349 and CD1350 (cprA, cprB, encoding the ATP–binding protein 
and the permease respectively) were increased by 5.3– and 2.9–fold, consistent with our hypothesis that increased 
levels of host or microbiota–derived antimicrobial peptides present in FW lead to increased expression of this 
specific mechanism.
Expression of motility genes is decreased in FW media. Bacterial flagella are self–assembling molec-
ular machines68,69, with flagella and type-IV pili comprising motility devices essential for the pathogenesis of 
certain bacteria70,71 including a variety of motile enteropathogens72. Flagellar biosynthesis is a highly–ordered 
process in which hierarchal control of gene expression ensures that synthesis of late–stage components is 
repressed until assembly of earlier components is complete73. Thus, only when the basal body and motor machin-
ery is in place, do late–stage genes, including flagellin (fliC) become expressed. Expression of motility genes in 
C. difficile is regulated by a sigma–28 factor encoded by CD0266 (fliA, or sigD) whose expression was 1.5–fold 
decreased in FW–grown cells. El Meouche et al.74 (2013) demonstrated that sigD acts as a positive regulator of 
both flagella and toxin gene expression in C. difficile. Decreased expression of sigD could therefore be partially 
responsible for the reduced expression of motility genes. In FW–grown C. difficile, expression of genes located 
broadly in the F3 loci (CD0245–CD0271), including those encoding components of the basal body, motor, hook 
and rod, exhibited 1.5– to 2–fold decreased expression. Gene expression in the F1 locus (CD0226–CD0240) was 
reduced between 2– and 5.7–fold, as would be expected if these gene products were not required until assembly 
of the basal body was complete. In addition, expression of fliC (CD0239) was decreased by 4.4–fold to ~20% of 
the level in the control, an observation corroborated by our qRT-PCR data (Fig. 4). flgN (CD0230) expression 
was reduced by 5.7–fold and we noted likewise that expression of genes in the interflagellar F2 locus (CD0240–
CD0244) decreased by just over three–fold in FW. Levels of transcript (Supplementary Table S3, base mean val-
ues), for class I flagellar genes were higher than those for the class II genes, with genes in the interflagellar locus 
Figure 6. Maximum fold–changes in gene expression within selected functional categories. Functional 
Categories with less than five differentially expressed genes were not included in the analysis. Transport, 
sporulation and conserved hypothetical protein–encoding genes exhibited the largest expressional changes in 
response to faecal water media.
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expressed at a yet lower level still, which is logical from an assembly perspective. Flagellar operon gene expression, 
and thus motility of C. difficile, decreases in FW concomitantly with increased expression of sporulation–asso-
ciated genes. The precise role of flagella in C. difficile pathogenesis is still unclear however, depending in many 
cases upon the strain tested55. Decreased FliC expression under clinically–relevant heat stress44–46, may enable 
better adherence to epithelial cells, a hypothesis supported by the work of Dingle et al.72 who assessed fliC and fliD 
disruption mutants, concluding that flagellar motility per se did not contribute to adherence to epithelial cells in 
vitro. Indeed, they argued that flagella were either not necessary for virulence, or that repression of motility could 
be a pathogenic mechanism. In a C. difficile dnaK mutant, lack of motility was underpinned by a 4–fold decrease 
in fliC expression with the mutant also exhibiting significantly enhanced biofilm–forming ability75. Other muta-
tional studies have also shown that non–flagellated C. difficile cells exhibit lower levels of toxin production76 in 
addition to increased sporulation as a result of the pleiotropic role of FliC in C. difficile gene regulation77.
In addition to changes in flagellar operon gene expression, we noted a 2– to 3–fold increase in expression of 
some genes in the secondary type IV pilus (TFP) locus. This increased expression of genes encoding a type–IV 
pilin, an associated type–II secretion system protein, and a pilus assembly ATPase (CD3294-6) suggests that 
pilus–driven motility may possibly be more important in a FW milieu and in certain stages of the infection pro-
cess. Regardless of the role of TFP during infection, bacterial flagella are known to promote intestinal lesions via 
host inflammatory responses: C. difficile FliC protein recognizes TLR5 and consequently activates the NF-κB and 
the MAPK signalling pathways that elicit synthesis of pro–inflammatory cytokines78. Such host receptors are not 
present in our experiment and decreased expression of flagellar loci may represent interplay between a putative 
motility phenotype and an adhesion, or indeed sporulation, phenotype. Nonetheless, flagella are energetically 
extravagant structures and, in the challenging environment of the gut, it makes strategic sense for motility in a 
semi–solid milieu to be driven by less resource–intensive structures such as type–IV pili.
Many Genes encoding Conserved Hypothetical Proteins are differentially expressed in FW 
media. The largest number of DE genes (n = 141) were placed in the ‘Similar to unknown proteins’ category 
and 19 of these had expressional changes of > 20–fold in FW–grown cells. None of the proteins encoded by 
these genes had predicted signal peptides79 and with the exception of CD1726 and CD3522, were all predicted 
by SecretomeP80 to be non–classically secreted. Nine of the gene products had PsortB81–predicted locations in 
the cytoplasmic membrane and the majority of these 141 proteins possessed no conserved domains that might 
indicate their potential function. Nonetheless, literature and database interrogation allowed us to link many to 
a role in sporulation. The most downregulated conserved hypothetical protein–encoding gene was CD2344, 
which has been identified as a putative succinate transporter with a role in C. difficile gut colonisation12. We 
have also shown here that expression of a variety of other genes in the succinate to butanoate fermentation path-
way–which lie transcriptionally downstream of CD2344 in the same operon structure82 (e.g. cat1, sucD, abfD, 
and cat2, 4hbd)–were decreased by ~4–fold in FW. A number of genes reported to be regulated by sporulation–
specific sigma factors41–43, including σK (CD3580 & CD1065), σG (CD2808 & CD2375) and σE (CD1063A-C, 
CD2150A & CD3522) were also DE in FW. Dembek83 reported that a large proportion of C. difficile spore tran-
scripts encoded proteins of unknown function and proposed that these were indicative of the difference between 
the transcriptional programme of vegetative cells and spores. Three such genes exhibited increased expression in 
FW–CD3551A (71–fold), CD2374 (30–fold) and CD2229 (36–fold). In addition, DE genes including CD1929, 
CD1884, CD2657, CD2374 and CD2375 were also reported by Janoir et al.55 to be expressed at higher levels in 
stationary phase C. difficile 630 cells at 14 h and 38 h–i.e. where the sporulation process would be well–established.
Conclusions
We set out to establish a new means of investigating gut pathogen biology in vitro. LC-MSn metabolomic analysis 
of FW allowed us to identify 30 individual components including urobilinogen, stercobilin and several cholic acid 
derivatives. Having established that the FW was–metabolomically–consistent with previous reports, we demon-
strated that in the presence of FW, growth of C. difficile strain 630 was largely unaffected, save for an increase in 
cell length that our transcriptome data indicates is most likely a prelude to sporulation. A primary question was 
whether C. difficile strain 630 could utilise components of FW. Our analysis showed that while FW metabolites 
were not further metabolised during growth, a set of previously unknown C. difficile–derived hexanoyl– and 
pentanoyl– derivatives of amino acids were produced. These metabolites are not only novel biomarkers for the 
presence of this pathogen, but also reflect previously unrecognised metabolic capabilities within C. difficile strain 
630. RNA sequencing showed clearly that the primary transcriptomic response of C. difficile strain 630 to FW was 
an acceleration of the sporulation cascade. FW–grown cells exhibited increases of up to 300–fold in the expres-
sion of sporulation–associated genes, with concomitant decreases in motility and toxin gene expression. These 
changes are reflective of the interplay between FW components and the expression of sensor kinase/response 
regulator systems, and transcription factors, many of which exhibited increased expression in FW–grown cells. 
Interestingly, none of the classical stress–response genes were differentially expressed, supporting the rationale 
that C. difficile adapts easily to a faecal milieu. The considerable modulation of a variety of transport systems is 
consistent with the addition of FW components to the growth media. Overall, therefore, our ex vivo FW model 
represents a new and unique means of assessing the response of C. difficile strain 630 to gut metabolites allowing 
us to describe, for the first time, the faecal milieu–associated physiological changes in this important pathogen.
Materials and Methods
Chemicals and Glassware. All chemicals and reagents of Analar grade or better were purchased from 
Sigma-Aldrich (Poole, UK) unless stated. Brain Heart Infusion (BHI) agar and broth and yeast extract were 
purchased from Oxoid (Basingstoke, UK). All molecular biology reagents were purchased from Invitrogen 
(Renfrewshire, UK) save for qPCR reagents, which were obtained from Roche Diagnostics (Hertfordshire, UK) 
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and random primers, which were obtained from Promega (Southampton, UK). Lysing Matrix A tubes were from 
MP Biomedicals (Cambridge, UK) and all glassware was cleaned with 1% Virkon (Antec Intl. Ltd., UK) overnight 
prior to steeping in 2% Decon (Decon Labs Ltd., UK) for 4 h prior to use.
Preparation of faecal water for inclusion in BHIS media. The Ulster University Research Ethics 
Committee exempted this study from review because donors were not involved in any intervention; the samples 
received were not collected by means of intervention and were used solely for preparation of a bacterial growth 
media. Written consent was obtained for provision of the donor faecal samples. Fresh faecal samples were pro-
vided by two apparently healthy individuals (2 males, age range 38–42 years, who had not taken antibiotics within 
the previous three months). Stool samples were collected from donors and stored at 4 °C for up to 2 h before 
processing. Faecal water was produced as described in Gill et al.32. In brief, the faecal sample was weighed, mixed 
1:1 wt/vol with ice cold 0.01 M phosphate buffered saline (PBS) then homogenised in a Seward 600 stomacher 
(2 × 2 min cycle). The resultant faecal slurry was centrifuged at 50,000 × g for 2 h at 4 °C in the 70.1Ti rotor of a 
Beckman L8-M centrifuge and the supernatant removed and filter–sterilised (0.22 μm filter) on ice before being 
aliquoted for storage at −70 °C.
Growth of Clostridium difficile strain 630. Clostridium difficile 630 (ATCC no. BAA-1382D-5) was 
grown under anaerobic conditions in a Don Whitley MACS MG500 anaerobic cabinet (Don Whitley Scientific 
Ltd, Yorkshire, UK) using a single gas mix (BOC, UK) of 80% N2, 10% CO2 and 10% H2, at 37 °C. Standard growth 
media was brain heart infusion broth supplemented with 5 g L−1 yeast extract and 1 g L−1 L-cysteine (BHIS). For 
media containing faecal water, 2–fold concentrated BHIS (50 mL) was prepared and a 50 mL aliquot of filter–ster-
ilised FW added to this aseptically post–autoclaving, resulting in 1 × BHIS containing 50% FW (“FW media”). 
Control media was prepared from 2–fold concentrated BHIS to which was added an equal volume of sterile PBS. 
Three starter cultures of C. difficile 630 were set up in 20 mL of FW media in glass universal bottles and each was 
inoculated with a single colony of freshly grown C. difficile 630 from a BHIS agar plate. Starter cultures were incu-
bated overnight and used to inoculate fresh media, in triplicate, at 5% (vol/vol). Growth was recorded hourly as 
attenuance at 650 nm (D650nm)44 against un–inoculated BHIS and FW media references. Multiple cell pellets were 
collected by centrifugation from all six cultures at mid–log phase of growth (D650nm = 0.6). Culture supernatants 
were removed to fresh tubes and both cell pellets and supernatants were placed briefly in liquid nitrogen before 
immediate transfer to −70 °C until required.
RNA extraction and quality control. RNA extraction was via a Qiagen RNeasy® Mini kit with the addi-
tion of a mechanical lysis step as described previously45. RNA was checked for absence of DNA contamination by 
PCR with gyrA, rpsJ, and adk primers (Table 3) followed by agarose gel electrophoresis and imaging under UV 
light. A Nanodrop™ 1000 spectrophotometer (Thermo Scientific) was used to quantify the amount of RNA in 
the samples and integrity of total RNA was then determined using an RNA 6000 Nano Assay kit with an Agilent 
2100 Bioanalyzer (Agilent Technologies, CA, USA) instrument as per the manufacturer’s instructions. Only RNA 
samples with RIN > 9.0 were used in subsequent procedures.
Transcriptome sequencing. RNA sequencing (RNAseq) and initial bioinformatics analysis was per-
formed at Deepseq (University of Nottingham, UK). RNA samples were shipped to Deepseq on dry ice and upon 
receipt, total RNA quality was once more assessed using the Agilent RNA 6000 Nano Kit (Agilent Technologies, 
5067–1511) on the Agilent 2100 Bioanalyzer. The total RNA concentration was measured using the Qubit RNA 
BR assay kit (Life technologies, Q10210). A 1 µg amount of Total RNA was used for rRNA depletion using the 
Ribo-Zero rRNA Removal Kit (Gram-Positive Bacteria) (Illumina, MRZGP126). Illumina stranded whole tran-
scriptome sequencing libraries were prepared using NEBNext Ultra Directional RNA library prep kit for Illumina 
(NEB, E7420S). The standard protocol for use with Ribosome Depleted RNA was followed except that, after 
second strand synthesis, the samples were precipitated with 1 µL (20 ng µL−1) glycogen and 1/10 vol. 3 M sodium 
acetate. Pellets were washed once with 80% ethanol, followed by 70% ethanol and after air-drying, pellets were 
resuspended in 58 µL of water. The standard protocol for use with Ribosome Depleted RNA was resumed for the 
remaining steps, except libraries were size selected using Agencourt AMPure XP beads at a 1.5 x ratio to retain the 
smaller sized fraction (~150 bp). The NEB Next Multiplex Oligos for Illumina kit (Primer set 1) (NEB, E7335S) 
was used to generate barcoded multiplex libraries. Library QC was performed using bioanalyser HS kit (Agilent 
biotechnologies, 5067–4626) and libraries were quantified using qPCR (Kapa Biosystems, KK4824). Libraries 
were pooled at desired concentrations, denatured and loaded for sequencing according to the manufacturer’s 
instructions. Sequencing was performed over 3 runs on the Illumina MiSeq sequencing platform to generate 
2 × 75 bp reads.
For differential gene expression analysis the sequencing reads were mapped onto the annotated C. difficile 
strain 630 reference genome (http://www.ncbi.nlm.nih.gov/nuccore/115249003) with appropriate alignment 
software. The aligned files were then processed for tag counts per location mapped or normalised tag counts 
(RPKMs) and differential gene expression analysis. The DeepSeq Filtering Pipeline for Read Mapping was 
used to filter reads with low sequencing score, in addition to reads aligned to adaptor sequences. Reads from 
the sequencer were QC checked using FASTQC, then trimmed and filtered for low quality bases and adaptor 
sequences, and QC checked once more. Reads that passed this filter were mapped onto the reference genome 
in the context of known gene exon coordinates using the bwa mapping tool (http://bio-bwa.sourceforge.net/). 
Read alignments were recorded in a BAM formatted alignment file (named *.bam), and companion BAM index 
file (named *.bam.bai). Read alignments, both primary and unique, were then filtered further according to their 
mapping quality score (MAPQ). For gene expression, MAPQ20 uniquely aligned reads were used to generate 
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counts per gene using ‘htseq-count’, which determines the number of uniquely aligned reads per gene (http://
www-huber.embl.de/users/anders/HTSeq/doc/count.html).
These counts were used as the input for the DESeq program84,85. DESeq models the distribution of the counts 
data in each sample and then compares the distributions to determine differentially expressed genes, with sig-
nificantly differentially expressed genes having an adjusted p value < 0.05. The program implements a single 
analytical approach and when RNA–seq samples with biological replicates are available, as is the case here, DESeq 
analyses the variance between them in order to better model the expression values of individual genes within the 
group of replicates.
The data discussed herein has been deposited in NCBI’s Gene Expression Omnibus86 repository (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112422) with accession number GSE112422.
Data processing. Transcriptome sequence data was obtained from DeepSeq as a summary MS Excel file 
containing a list of genes with cognate base mean values for BHI medium (BHI, base mean A) and faecal water 
medium (FW, base mean B) growth conditions, in addition to p value, p-adjusted value and the ratio of FW/BHI 
base mean values, sorted by p-adjusted (padj) value from low to high. Some 1687 genes had p < 0.05, 1153 genes 
had padj < 0.05, reducing to 889 genes for which padj was < 0.001. The base mean values for these 889 genes 
were used to calculate log2 values for each FW/BHI ratio, from which was calculated the absolute fold–change 
for each gene. Subsequent analysis was undertaken with the statistically robust master list of 889 differentially 
expressed (DE) genes with pdaj < 0.001 and FC > 1.45. The NCBI C. difficile strain 630 genome (http://www.
ncbi.nlm.nih.gov/nuccore/115249003) was used as a starting point for addition of the C. difficile strain 630 locus 
annotations87,88, in addition to protein name and Subtilist functional category89,90. This process was carried out 
essentially as in our previous work45,46 using the NCBI CDD database, BioCyc pathway tools and metacyc visual 
pathways software82,91,92 combined with literature searching to arrive at a functional role/categorisation and to 
identify predicted co–regulated genes and operon structures (for complete list of DE genes see Supplementary 
Table S3).
Reverse transcription and qPCR. As in our previous work44,45 differential gene expression data was cor-
roborated using qRT-PCR, on aliquots of the same RNA samples that were sent for sequencing. cDNA was pre-
pared from 500 ng aliquots of the extracted RNA samples and 50 ng of random hexamer primer (Promega, WI, 
USA) with a SuperScript II Reverse Transcriptase kit (Invitrogen, Renfrewshire, UK). Successful reverse tran-
scription and generation of cDNA was confirmed by PCR using rpsJ, gyrA or adk primers (Table 3), as compared 
to the “minus RT” controls. Quantitative PCR (qPCR) was performed on a LightCycler480 instrument using a 
Master SYBR Green 1 kit (Roche Diagnostics, UK). Standard curves were prepared by creating a 5–fold serial 
dilution (1, 1:5, 1:25, 1:125, 1:625, 1:3125, and 1:15125) of the pooled cDNA samples from all cultures with 
nuclease-free water. qPCR target run reactions were set up in technical triplicates. Bulk mastermix containing 
5 µL of 2–fold concentrated master mix, 1 µL each of forward and reverse primer (at a concentration of 10 µM), 
2 µL of nuclease free H2O and 1 µL of a 1–in–10 dilution of the relevant cDNA template was prepared and 10 µL 
aliquots of this added to the plate. qPCR cycling conditions comprised an initial denaturation stage of 95 °C for 
5 min followed by 40 cycles of 95 °C for 10 s, 57 °C for 10 s and 72 °C for 10 s. Melting curve analysis of target runs, 
in addition to “no template” and “no reverse transcriptase” controls confirmed the specificity of amplification.
Roche Rel-Quant software (Roche Diagnostics, UK) was used to generate a Cq value for each sample using 
the second derivative maximum method. Cq values were transferred to Excel and the arithmetic mean of tech-
nical replicates was determined. These values were then log transformed to relative quantities (RQ) using the 
Gene Locus Description Primer Sequence (5′ → 3′)
Binding 
position
Product 
size (bp)
Annealing 
temperature (°C) Reference
rho CD3487 Transcription termination factor Rho
rho-F
rho-R
CATCAAGCAATAAATCATCTC
CTGGTTCTAGGATGGATGATG 141–293 153 57 Metcalf et al.
96
gyrA CD0006 Gyrase subunit A gyrA-FgyrA-R
CTCGTATTGTTGGGGACGTT
ATCCCCATCAACAGAACCAA 197–342 146 57 Denève et al.
97
adk CD0091 Adenylate kinase adk-Fadk-R
GTGTATGTGATGTATGCCAAG
CCTAAGGCTGCGACAATATC 443–638 196 57 Metcalf et al.
96
rpsJ CD0072 30 S ribosomal protein S10 RpsJ-FrpsJ-R
GATCACAAGTTTCAGGACCTG
GTCTTAGGTGTTGGATTAGC 101–251 151 57 Metcalf et al.
96
groES CD0193 10 kDa chaperone groES-FgroES-R
AGTTTTACCAGGAGCAGCTAAAG
CCTTATCTCCCACTGTCAATTCC 75–190 116 57 This study
groEL CD0194 60 kDa chaperone groEL-FgroEL-R
TTGCTGGAGGAGTAGCTGTTG
AAAAGCAGTTCCTCCACCAG 1109–1251 143 57 This study
fliC CD0239 Flagellin subunit fliC-FfliC-R
TGATGATGCTGCTGGACTTG
ACGAACCTTCTGCTGTTTGTAC 120–238 119 57 This study
fliD CD0237 Flagellar cap protein fliD-FfliD-R
AGCTGGACAAATTGCCAGTG
CCTTGGTCATCAGTTACATCAGC 621–734 114 57 This study
tcdA CD0663 Toxin A tcdA-FtcdA-R
AGCTTTCGCTTTAGGCAGTG
ATGGCTGGGTTAAGGTGTTG 1121–1250 129 57 This study
spoVB CD3498 Stage 5 sporulation protein B spoVB-FspoVB-R
ATTCAGGGAATGGGAAAACC
TTAATCATGGCTGCCACAAA 1165–1325 161 57 This study
Table 3. PCR primers.
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information gained from standard curves previously constructed for each primer pair, thus ensuring PCR effi-
ciencies were calculated accurately for each gene. All target gene RQs were normalised against the geometric 
mean of the reference gene RQs by dividing the former by the later (target/housekeeping) to generate normalised 
relative quantity (NRQ) values. Control sample NRQ values (BHIS) were subsequently used as a calibrator and 
corrected to 1 with all experimental NRQ values (FW media) being expressed as a relative expression ratio to 
the calibrator for each gene. Values were subsequently expressed as fold change ratios relative to the BHI control 
(Supplementary Data File 1, Table S4).
Liquid Chromatography-Mass Spectrometry (LC–MS) analysis of culture supernatant samples. 
LC–MSn Analysis. Culture media samples were frozen and transported to the Hutton Institute on dry ice where 
they were stored at −70 °C prior to analysis. After thawing on ice, samples (1 mL) were vortexed then transferred 
to 2 mL microcentrifuge tubes and centrifuged at 10,000 × g for 10 min at 5 °C in a refrigerated microfuge. A 
sub-sample (0.5 mL) was removed and placed in a 0.45 µm PTFE filter vial (Thomson Instrument Company, sup-
plied by Bioprocess Engineering Services Ltd, Kent, UK) prior to analysis using the LTQ-Orbitrap XL LC−MS 
system. Samples were analysed using a LC system consisting of a quaternary pump (Thermo Fisher Scientific, 
Accella 600) and a PDA detector (Thermo Fisher Scientific, Accella) coupled to an LTQ Orbitrap XL mass spec-
trometer (Thermo Fisher Scientific, Hemel Hempstead, U.K.). Duplicate 10 μL samples were injected in part-loop 
mode onto a 2 × 150 mm (4 μm) Synergy Hydro-RP 80Ä column fitted with a C18 4 × 2 mm Security Guard 
cartridge (Phenomenex Ltd, Macclesfield, UK). Autosampler and column temperatures were maintained at 6 °C 
and 30 °C, respectively. The samples were analysed at a flow rate of 0.3 mL/min using a binary mobile phase of 
(A) 0.1% aqueous formic acid and (B) 0.1% formic acid in acetonitrile/water (1:1, vol/vol) with the following 
gradient: 0–4 min, 5% B; 4–22 min, 5–50% B; 22–32 min, 50–10 0% B. Following each analysis, the column was 
equilibrated for 5 min under starting solvent conditions. Mass detection was carried out using an LTQ Orbitrap 
XL mass spectrometer in negative ESI mode. Two scan events were employed; full-scan analysis (130–2000 m/z) 
in profile peak mode was followed by data–dependent MS/MS in centroid peak mode of the three most intense 
ions using a collision energy of 45 eV, activation Q of 0.25, trapping time 30 ms, and isolation width of 2 m/z. Full 
scan data were collected at a mass resolution of 30,000 (full width half maximum–FWHM –defined at m/z 400). 
Scan speeds of 0.1 s and 0.4 s were applied in the LTQ and FT-MS respectively. The Automatic Gain Control was 
set to 1 × 105 and 5 × 105 for the LTQ and FT-MS, respectively. Prior to the analytical run, the LTQ and FT-MS 
were tuned to optimise conditions for the detection of ions in the mid detection range of m/z 80–2000, as well 
as being calibrated with the manufacturer’s recomended calibration mixture. ESI conditions were as follows: 
spray voltage −3.5 kV (ESI-); sheath gas 60; aux gas 30; capillary voltage −35 V (ESI−); tube lens voltage −100 V 
(ESI-); capillary temperature 380 °C. For the first three min of analysis, the eluent flow was directed to waste. All 
predicted formula data presented are accurate at <2 ppm.
Raw LC–MS data processing. The raw LC–MS data files were first converted into an MZML centroid for-
mat using the Proteowizard MSConvert software package. Each MZML based three-dimensional data matrix 
(intensity × m/z × time) for each per sample was converted (or deconvoluted) into a vector of peak responses, 
where a peak response is defined as the sum of intensities over a window of specified mass and time range (e.g. 
m/z = 102.1 ± 0.01 and time = 130 ± 10 s) using the freely available XCMS software (http://masspec.scripps.edu/
xcms/xcms.php). A full description of the data deconvolution method performed within XC–MS is available93. 
In the current work, the band width setting was adjusted from 10 to 20 to accommodate the wider peak widths 
that result from HPLC as compared to UHPLC. The XC–MS deconvolution produced an MS Excel based X by Y 
matrix output as peak areas for detected peaks.
Statistical analysis of LC–MS data. The data from XCMS was loaded into SIMCA-P 12.0.1.0 software (Umetrics, 
available at https://umetrics.com) and principal components analysis (PCA) was carried out. PCA, using univari-
ate scaling, clearly showed that the FW samples separated from the BHI-only samples on score 1, which explained 
52% of the variation of the dataset. The beginning and end samples were clearly separated in scores 3 and 4 of the 
PCA, which explained 10% and 5%, respectively, of the variation (Supplementary Data File 1, Fig. S1). Following 
this robust PCA, a further discriminant analysis (optimized partial least squares, OPLS-DA) was performed with 
two classifications (“start” and “end” of incubation), resulting in a model that described ~9% of the variation with 
a Q2 (cum) value of 0.851 (Supplementary Data File 1, Fig. S2).
Using the loadings plots from this OPLS–DA plot (Supplementary Data File 1, Fig. S3), the m/z signals that 
drove the separation for the “end of incubation” could be extracted into an Excel file (Supplementary Data File 1, 
Table S5). Returning to the original XCMS data, the abundance of these components before and after incubation 
(for both biological and technical replicates) was plotted as peak areas (Supplementary Data File 1, Figs S4, S5). 
Over 120 “potential up-at-end” components were selected by this process and the graphs were quality checked 
to select only those with a clear distinction between before and after peak areas (e. g. with no overlap between 
before and after replicates). A final step of manual peak checking was carried out to check MS peak quality and to 
exclude peaks of very low abundance which often yielded no MS2 data.
The XCMS data selected each m/z peak (along with any type of adduct ion(s) present) and the PutMedID set 
of workflows within the Taverna Workbench 1.7.2 software package94 was applied to predict putative metabolite 
identities using a library of known plant metabolites obtained from the Plant Metabolic Network PlantCyc data-
base (http://www.plantcyc.org). In many cases, however, the putative identifications were not supported by sub-
sequent examination (e. g.) of MS2 data. Therefore, further manual putative peak assignation was carried out by 
comparing the predicted molecular formulae and MS2 data with various databases and literature (Supplementary 
Data File 1, and Tables 1, 2).
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Equipment and settings. Images shown in Figs 1, 3, 4 and 5 were produced using MS Excel, individually 
exported in PDF and imported into GiMP 2.8 for construction and final labelling. MS traces comprising Fig. 2A,B 
were exported from the resident MS Xcalibur software (Thermo Fisher Scientific, Hemel Hempstead, U.K.) into 
a Word document. After conversion into Microsoft Office drawing objects, the traces were edited to incorporate 
peak labels in Microsoft Word, exported as.jpg files and imported into GiMP 2.8 for construction and final label-
ling of Fig. 2.
Images in Supplementary data file 1 (Figs S1, S3) were made using the graphics package inherent in SIMCA 
then copied into a Word document. Figs S4 and S5 were made using the graphic package in GENESTAT, then cop-
ied into a Word document. The MS traces comprising Fig. S6 were exported from the resident MS Xcalibur soft-
ware (Thermo Fisher Scientific, Hemel Hempstead, U.K.) into a Word document. After conversion into Microsoft 
Office drawing objects, the traces were edited to incorporate peak labels in Microsoft Word. All Supplementary 
Figures S1–S6 were saved as a single pdf file.
Ethical Approval. The Ulster University Research Ethics Committee exempted this study from review 
because donors were not involved in any intervention; the samples received were not collected by means of inter-
vention and were used solely for preparation of a bacterial growth media. Written consent was obtained for pro-
vision of the donor faecal samples.
Data Availability
All data generated or analysed during this study are included in this published article (and in Supplementary 
Information files). The RNAseq datasets generated and analysed in this work are available in the NCBI GEO re-
pository (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112422) with accession number GSE112422.
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